Key result
Lidocaine for spinal anesthesia significantly increased the risk of transient neurological symptoms compared to other local anesthetics (10.8% vs 2.2%; RR 4.12; 95% CI 3.13 to 5.43; p < 0.001).
Why the study?
Previous meta-analyses showed lidocaine in spinal anesthesia may increase TNS risk but lacked data on certain local anesthetics, necessitating further evaluation.
Does lidocaine increase the risk of transient neurological symptoms compared to other local anesthetics in patients undergoing spinal anesthesia?
Meta-Analysis (n=4,733)
Does lidocaine increase the risk of transient neurological symptoms compared to other local anesthetics in patients undergoing spinal anesthesia?
Relative Risk: 4.12 (95% CI 3.13–5.43)
Absolute Event Rate: 10.8% vs 2.2%
p-value: p=< 0.001
Lidocaine for spinal anesthesia significantly increases the risk of transient neurological symptoms compared to most other local anesthetics, particularly when hyperbaric or isobaric formulations are used.
Avoid lidocaine for spinal anesthesia to minimize TNS risk; confirms preference for alternatives in Level 1 evidence.
The use of lidocaine in spinal anesthesia may increase the risk of transient neurological symptoms (TNS) according to previous meta-analyses. However, the previous meta-analyses lacked data on some other local anesthetics and thus, more evaluations are still needed to compare the effect of lidocaine on the development of TNS. The objective of this study was to compare the risk of TNS according to lidocaine versus other local anesthetics in patients undergoing spinal anesthesia. A total of 39 randomized controlled trials with 4733 patients were analyzed. The incidence of TNS was 10.8% in the lidocaine group and was 2.2% in the control groups (risk ratio (RR) 4.12, 95% confidence interval (CI) 3.13 to 5.43, p < 0.001). In subgroup analysis, lidocaine increased the incidence of TNS compared with other local anesthetics except mepivacaine, ropivacaine or sameridine. The risk of TNS was higher in the hyperbaric (p < 0.001) or isobaric lidocaine (p < 0.001) group compared with the control group, but there were no differences found between the two groups when hypobaric lidocaine was administered (p = 1.00). This study confirmed that lidocaine for spinal anesthesia still causes TNS more frequently than most other local anesthetics, especially when hyperbaric or isobaric lidocaine was used.
No takes yet. Share an insight, caveat, or question.
Koo et al. (2020) conducted a meta-analysis in patients undergoing spinal anesthesia (n=4,733). Lidocaine vs. other local anesthetics was evaluated on transient neurological symptoms (TNS) (RR 4.12, 95% CI 3.13 to 5.43, p=< 0.001). Lidocaine for spinal anesthesia significantly increased the risk of transient neurological symptoms compared to other local anesthetics (10.8% vs 2.2%; RR 4.12; 95% CI 3.13 to 5.43; p < 0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: